Cash Flow Statement
Growth Metrics

Biolife Solutions (BLFS) Net Income towards Common Stockholders (2010 - 2025)

Biolife Solutions (BLFS) reported Net Income towards Common Stockholders of $7.5 million for Q4 2025, down 37.28% year-over-year from $12.0 million in Q4 2024, and up 147.58% on a QoQ basis from -$15.8 million in Q2 2025.

Biolife Solutions (BLFS) has 16 years of Net Income towards Common Stockholders data on file, last reported at $7.5 million in Q4 2025.

  • Quarterly Net Income towards Common Stockholders fell 37.28% year-over-year to $7.5 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$8.3 million (up 23.52% YoY) and the FY2025 annual result came in at $7.5 million, up 166.1% from the prior year.
  • Net Income towards Common Stockholders climbed to $7.5 million in Q4 2025 per BLFS's latest filing, from -$15.8 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $12.0 million in Q4 2024 and bottomed at -$72.9 million in Q2 2022.
  • The 5-year median for Net Income towards Common Stockholders is -$10.2 million (2024), against an average of -$11.9 million.
  • The widest annual swing landed in 2022, when Net Income towards Common Stockholders plunged 13159.49%; it then soared 189.78% in 2024.
  • Tracing BLFS's Net Income towards Common Stockholders over 5 years: stood at -$15.7 million in 2021, then tumbled by 212.41% to -$49.2 million in 2022, then surged by 72.79% to -$13.4 million in 2023, then soared by 189.78% to $12.0 million in 2024, then sank by 37.28% to $7.5 million in 2025.
  • Per Business Quant, the three latest BLFS Net Income towards Common Stockholders figures stand at $7.5 million (Q4 2025), -$15.8 million (Q2 2025), and -$448000.0 (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 826.00 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -274.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 398.73 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 135.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 13.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 130.80 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 112.77 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 2.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 72.77 Mn
10 Biolife Solutions 1.20 Bn 1.12 Bn 17.50 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 7.54 Mn
Jun 30, 2025 -15.84 Mn
Mar 31, 2025 -448,000.00
Dec 31, 2024 12.01 Mn
Sep 30, 2024 -1.70 Mn
Jun 30, 2024 -20.72 Mn
Mar 31, 2024 -10.22 Mn
Dec 31, 2023 -13.38 Mn
Sep 30, 2023 -15.80 Mn
Jun 30, 2023 -5.52 Mn
Mar 31, 2023 -13.71 Mn
Dec 31, 2022 -49.19 Mn
Sep 30, 2022 -10.32 Mn
Jun 30, 2022 -72.88 Mn
Mar 31, 2022 -7.42 Mn
Dec 31, 2021 -15.75 Mn
Sep 30, 2021 79,000.00
Jun 30, 2021 7.88 Mn
Mar 31, 2021 -1.12 Mn
Dec 31, 2020 -6.11 Mn
Sep 30, 2020 -1.13 Mn
Jun 30, 2020 -16.38 Mn
Mar 31, 2020 18.36 Mn
Dec 31, 2019 2.98 Mn
Sep 30, 2019 8.38 Mn
Jun 30, 2019 3.43 Mn
Dec 31, 2018 20.87 Mn
Sep 30, 2018 -24.55 Mn
Jun 30, 2018 -26.44 Mn
Dec 31, 2017 -664,530.00
Sep 30, 2017 -424,968.00
Jun 30, 2017 -768,212.00
Mar 31, 2017 -870,290.00
Dec 31, 2016 -3.32 Mn
Sep 30, 2016 -969,001.00
Jun 30, 2016 -1.60 Mn
Mar 31, 2016 -1.49 Mn
Dec 31, 2015 -1.40 Mn
Sep 30, 2015 -1.30 Mn
Jun 30, 2015 -1.16 Mn
Mar 31, 2015 -1.16 Mn
Dec 31, 2014 -1.00 Mn
Sep 30, 2014 -874,513.00
Jun 30, 2014 -887,873.00
Mar 31, 2014 -546,349.00
Dec 31, 2013 -284,751.00
Sep 30, 2013 -110,093.00
Jun 30, 2013 -268,399.00
Mar 31, 2013 6,776.00
Dec 31, 2012 -493,191.00
Sep 30, 2012 -334,262.00
Jun 30, 2012 -490,173.00
Mar 31, 2012 -358,041.00
Dec 31, 2011 -384,111.00
Sep 30, 2011 -456,465.00
Jun 30, 2011 -425,249.00
Mar 31, 2011 -614,819.00
Dec 31, 2010 -1.34 Mn
Sep 30, 2010 -135,606.00
Jun 30, 2010 -245,758.00